Xtalpi forecasts H1 net loss RMB 215 million-RMB 275 million vs year-ago profit

• XtalPi guided for a net loss attributable to equity holders of RMB 215 million to RMB 275 million for H1 ended June 30, 2026.
• That compares with a net profit of RMB 82.8 million a year earlier, marking a swing to loss.
• Revenue forecast at RMB 380 million to RMB 400 million versus RMB 517.1 million, reflecting a high base from a USD 51 million upfront last year.
• Booked USD 19 million second payment this period, recognized as drug discovery solutions revenue; excluding the project, revenue seen at least RMB 250 million.
• R&D expense expected at least RMB 340 million, up over 50%, driven by investment in autonomous labs, agentic systems, pipelines, multimodal platforms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260724-12256542), on July 24, 2026, and is solely responsible for the information contained therein.